Thiadiazinones

Thiadiazinones of the formula I wherein A is -CHR4-CHR5-, -CH2-CR4R5-, -CR4R5-CH2-, -CHR4-CHR5-CH2-, -CHR4-CH2-CHR5-, -CH2-CHR4-CHR5-, -CR4R5-CH2CH2-, -CH2-CR4R5-CH2- or -CH2CH2-CR4R5-, R1, R2, R3, R4 and R5 are each independently H, C1-5-alkyl, C2-5-alkenyl or C2-5-alkinyl, R3 is also C1-15-acyl, R...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	JONAS ROCHUS DR, SCHLIEP HANS-JOCHEN, KLOCKOW MICHAEL DR, PIULATS JAIME DR, LUES INGEBORG DR
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	JONAS ROCHUS DR SCHLIEP HANS-JOCHEN KLOCKOW MICHAEL DR PIULATS JAIME DR LUES INGEBORG DR
description	Thiadiazinones of the formula I wherein A is -CHR4-CHR5-, -CH2-CR4R5-, -CR4R5-CH2-, -CHR4-CHR5-CH2-, -CHR4-CH2-CHR5-, -CH2-CHR4-CHR5-, -CR4R5-CH2CH2-, -CH2-CR4R5-CH2- or -CH2CH2-CR4R5-, R1, R2, R3, R4 and R5 are each independently H, C1-5-alkyl, C2-5-alkenyl or C2-5-alkinyl, R3 is also C1-15-acyl, R6 is H, alkyl, alkoxyl, OH, F, Cl, Br or I and Z is (H, H), (H, alkyl), (alkyl, alkyl) or O, the alkyl, alkenyl, alkinyl and/or alkoxy groups in each case containing up to 5 C atoms, but wherein, if A is -CH2CH2- and Z is O, one of the radicals R1, R2, R3 and R6 must be other than H, and salts thereof demonstrate positive inotropic action and are suitable for combating cardiovascular diseases.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IE62113B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IE62113B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IE62113B13</originalsourceid><addsrcrecordid>eNrjZOALychMTMlMrMrMy89LLeZhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfGermZGhobGTobGBBUAAMCZHWE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Thiadiazinones</title><source>esp@cenet</source><creator>JONAS ROCHUS DR ; SCHLIEP HANS-JOCHEN ; KLOCKOW MICHAEL DR ; PIULATS JAIME DR ; LUES INGEBORG DR</creator><creatorcontrib>JONAS ROCHUS DR ; SCHLIEP HANS-JOCHEN ; KLOCKOW MICHAEL DR ; PIULATS JAIME DR ; LUES INGEBORG DR</creatorcontrib><description>Thiadiazinones of the formula I wherein A is -CHR4-CHR5-, -CH2-CR4R5-, -CR4R5-CH2-, -CHR4-CHR5-CH2-, -CHR4-CH2-CHR5-, -CH2-CHR4-CHR5-, -CR4R5-CH2CH2-, -CH2-CR4R5-CH2- or -CH2CH2-CR4R5-, R1, R2, R3, R4 and R5 are each independently H, C1-5-alkyl, C2-5-alkenyl or C2-5-alkinyl, R3 is also C1-15-acyl, R6 is H, alkyl, alkoxyl, OH, F, Cl, Br or I and Z is (H, H), (H, alkyl), (alkyl, alkyl) or O, the alkyl, alkenyl, alkinyl and/or alkoxy groups in each case containing up to 5 C atoms, but wherein, if A is -CH2CH2- and Z is O, one of the radicals R1, R2, R3 and R6 must be other than H, and salts thereof demonstrate positive inotropic action and are suitable for combating cardiovascular diseases.</description><edition>5</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1994</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19941214&DB=EPODOC&CC=IE&NR=62113B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19941214&DB=EPODOC&CC=IE&NR=62113B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JONAS ROCHUS DR</creatorcontrib><creatorcontrib>SCHLIEP HANS-JOCHEN</creatorcontrib><creatorcontrib>KLOCKOW MICHAEL DR</creatorcontrib><creatorcontrib>PIULATS JAIME DR</creatorcontrib><creatorcontrib>LUES INGEBORG DR</creatorcontrib><title>Thiadiazinones</title><description>Thiadiazinones of the formula I wherein A is -CHR4-CHR5-, -CH2-CR4R5-, -CR4R5-CH2-, -CHR4-CHR5-CH2-, -CHR4-CH2-CHR5-, -CH2-CHR4-CHR5-, -CR4R5-CH2CH2-, -CH2-CR4R5-CH2- or -CH2CH2-CR4R5-, R1, R2, R3, R4 and R5 are each independently H, C1-5-alkyl, C2-5-alkenyl or C2-5-alkinyl, R3 is also C1-15-acyl, R6 is H, alkyl, alkoxyl, OH, F, Cl, Br or I and Z is (H, H), (H, alkyl), (alkyl, alkyl) or O, the alkyl, alkenyl, alkinyl and/or alkoxy groups in each case containing up to 5 C atoms, but wherein, if A is -CH2CH2- and Z is O, one of the radicals R1, R2, R3 and R6 must be other than H, and salts thereof demonstrate positive inotropic action and are suitable for combating cardiovascular diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1994</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZOALychMTMlMrMrMy89LLeZhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfGermZGhobGTobGBBUAAMCZHWE</recordid><startdate>19941214</startdate><enddate>19941214</enddate><creator>JONAS ROCHUS DR</creator><creator>SCHLIEP HANS-JOCHEN</creator><creator>KLOCKOW MICHAEL DR</creator><creator>PIULATS JAIME DR</creator><creator>LUES INGEBORG DR</creator><scope>EVB</scope></search><sort><creationdate>19941214</creationdate><title>Thiadiazinones</title><author>JONAS ROCHUS DR ; SCHLIEP HANS-JOCHEN ; KLOCKOW MICHAEL DR ; PIULATS JAIME DR ; LUES INGEBORG DR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IE62113B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1994</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JONAS ROCHUS DR</creatorcontrib><creatorcontrib>SCHLIEP HANS-JOCHEN</creatorcontrib><creatorcontrib>KLOCKOW MICHAEL DR</creatorcontrib><creatorcontrib>PIULATS JAIME DR</creatorcontrib><creatorcontrib>LUES INGEBORG DR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JONAS ROCHUS DR</au><au>SCHLIEP HANS-JOCHEN</au><au>KLOCKOW MICHAEL DR</au><au>PIULATS JAIME DR</au><au>LUES INGEBORG DR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Thiadiazinones</title><date>1994-12-14</date><risdate>1994</risdate><abstract>Thiadiazinones of the formula I wherein A is -CHR4-CHR5-, -CH2-CR4R5-, -CR4R5-CH2-, -CHR4-CHR5-CH2-, -CHR4-CH2-CHR5-, -CH2-CHR4-CHR5-, -CR4R5-CH2CH2-, -CH2-CR4R5-CH2- or -CH2CH2-CR4R5-, R1, R2, R3, R4 and R5 are each independently H, C1-5-alkyl, C2-5-alkenyl or C2-5-alkinyl, R3 is also C1-15-acyl, R6 is H, alkyl, alkoxyl, OH, F, Cl, Br or I and Z is (H, H), (H, alkyl), (alkyl, alkyl) or O, the alkyl, alkenyl, alkinyl and/or alkoxy groups in each case containing up to 5 C atoms, but wherein, if A is -CH2CH2- and Z is O, one of the radicals R1, R2, R3 and R6 must be other than H, and salts thereof demonstrate positive inotropic action and are suitable for combating cardiovascular diseases.</abstract><edition>5</edition><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_IE62113B1
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	Thiadiazinones
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T10%3A11%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JONAS%20ROCHUS%20DR&rft.date=1994-12-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIE62113B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true